Priority Date: 26.10.11 (US 201161551918P)

MONOCLONAL ANTIBODIES AND METHODS OF USE

  • Application ID: EP12842976
  • Status: EXAMINATION IN PROGRESS

Applicants

Technology company logo small
Technology Company
Technology company logo small
Technology Company

Attorneys

no operation time available
3 offices
Technology Company
no operation time available
3 offices
Technology Company
no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Eli Lilly and Company Limited is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 221 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 26.10.2011 - Priority Date (US 201161551918P)
  • 02.05.2013 - Publication A2 (WO2013063186)
  • 03.09.2014 - Publication A2 (EP2771694)

IPC Classification